KalVista Pharmaceuticals Presents New Data Highlighting the Burden of Injectable On-Demand Treatment in Young Children with Hereditary Angioedema
Go back to KalVista Pharmaceuticals Presents New Data Highlighting the Burden of Injectable On-Demand Treatment in Young Children with Hereditary Angioedema| (NASDAQ: KALV) | Delayed: 27.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $27.00 | 52 Week High | $ | |||
| Open | $27.00 | 52 Week Low | $ | |||
| Day High | $27.00 | P/E | N/A | |||
| Day Low | $27.00 | EPS | $ | |||
| Volume | 10,757 | |||||
